1. Ciotti M, Ciccozzi M, Terrinoni A, Jiang W-C, Wang C-B, Bernardini S. The covid-19 pandemic. Crit Rev Clin Lab Sci. 2020;57:365-388.
2. Daniel SJ. Education and the covid-19 pandemic. Prospects (Paris). 2020;49:91-96.
3. https://www.worldometers.info/coronavirus/
4. Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in covid-19 patients: A systematic review and meta-analysis. J Prev Med Hyg. 2020; 61(3):E304-E312.
5. Nile SH, Nile A, Qiu J, et al. Covid-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020; 53:66-70.
6. Yong SJ. Long covid or post-covid-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021; 53:737-754.
7. Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with covid-19: A systematic review and meta-analysis. J Infect. 2020;81:266-275.
8. Zargaran FN, Rostamian M, Kooti S, Madanchi H, Ghadiri K. Co-infection of covid-19 and parasitic diseases: A systematic review. Parasit Epidemiol Control. 2023; 21:e00299.
9. Brown SP, Grenfell BT. An unlikely partnership: Parasites, concomitant immunity and host defence. Proc Biol Sci. 2001;268:2543-2549.
10. Khan IA, Moretto M. Immune responses to Toxoplasma gondii. Curr Opin Immunol. 2022;77:102226.
11. Kochanowsky JA, Koshy AA. Toxoplasma gondii. Curr Biol. 2018;28:R770-R771.
12. Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis. 2012;44:805-814.
13. Ahmed M, Sood A, Gupta J. Toxoplasmosis in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2020; 255:44-50.
14. Fisch D, Clough B, Frickel E-M. Human immunity to Toxoplasma gondii. PLoS Pathog. 2019;15:e1008097.
15. Maizels RM, McSorley HJ. Regulation of the host immune system by helminth parasites. J Allergy Clin Immunol. 2016; 138:666-675.
16. Wakelin D. Immunity to parasites: How parasitic infections are controlled. Cambridge University Press; 1996.
17. Zhou Y, Fu B, Zheng X, et al. Pathogenic t-cells and inflammatory monocytes incite inflammatory storms in severe covid-19 patients. Natl Sci Rev. 2020;7:998-1002.
18. Sharaf-El-Deen SA. Toxoplasma gondii as a possible risk factor for covid-19 severity: A case-control study. Egyptian Journal of Medical Microbiology. 2021;30:125-132.
19. Roe K. The symptoms and clinical manifestations observed in covid-19 patients/long covid-19 symptoms that parallel Toxoplasma gondii infections. J Neuroimmune Pharmacol. 2021;16:513-516.
20. Meira CS, Pereira-Chioccola VL, Vidal JE, et al. Cerebral and ocular toxoplasmosis related with ifn-γ, tnf-α, and il-10 levels. Front Microbiol. 2014;5:492.
21. Mahmoudzadeh S, Nozad Charoudeh H, Marques CS, Bahadory S, Ahmadpour E. The role of il-12 in stimulating nk cells against Toxoplasma gondii infection: A mini-review. Parasitol Res. 2021;120:2303-2309.
22. Ghosh D, Walton JL, Roepe PD, Sinai AP. Autophagy is a cell death mechanism in Toxoplasma gondii. Cell Microbiol. 2012;14:589-607.
23. Seabra SH, de Souza W, DaMatta RA. Toxoplasma gondii partially inhibits nitric oxide production of activated murine macrophages. Exp Parasitol. 2002;100:62-70.
24. MacRae JI, Sheiner L, Nahid A, et al. Mitochondrial metabolism of glucose and glutamine is required for intracellular growth of Toxoplasma gondii. Cell Host Microbe. 2012;12:682-692.
25. Jafari MM, Tabrizi ZA, Dayer MS, et al. Immune system roles in pathogenesis, prognosis, control, and treatment of Toxoplasma gondii infection. Int Immunopharmacol. 2023;124 (Pt A):110872.
26. Tay MZ, Poh CM, Rénia L, et al. The trinity of covid-19: Immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363-374.
27. Roe K. The link between Toxoplasma gondii infections and higher mortality in covid-19 patients having schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2022;272:167-168.
28. Montazeri M, Nakhaei M, Fakhar M, et al. Exploring the association between latent Toxoplasma gondii infection and covid-19 in hospitalized patients: First registry-based study. Acta Parasitol. 2022;67:1172-1179.
29. Gibson PG, Qin L, Puah SH. Covid‐19 acute respiratory distress syndrome (ards): Clinical features and differences from typical pre‐covid‐19 ards. Med J Aust. 2020;213:54-56.e1.
30. Butcher BA, Denkers EY. Mechanism of entry determines the ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production. Infect Immun. 2002;70:5216-5224.
31. Heidari A, Hezarosi M, Nasserkhail E, et al. The parasitic contamination of edible raw vegetables in karaj, iran in 2017. Iran J Public Health. 2020;49:2435-2437.
32. Dalimi A, Abdoli A. Latent toxoplasmosis and human. Iran J Parasitol. 2012; 7(1):1-17.
33. Araujo F, Remington J. Toxoplasmosis in immunocompromised patients. Eur J Clin Microbiol. 1987; 6(1):1-2.
34. Ghaffari S, Kalantari N, Gorgani-Firouzjaee T, et al. Is covid-19 associated with latent toxoplasmosis? Environ Sci Pollut Res Int. 2021;28:67886-67890.
35. Yazdanbakhsh M, Matricardi PM. Parasites and the hygiene hypothesis: Regulating the immune system? Clin Rev Allergy Immunol. 2004;26:15-24.